ЭКСПЕРИМЕНТАЛЬНОЕ ФОРМИРОВАНИЕ ЦИРРОЗА ПЕЧЕНИ ЖИВОТНЫХ В ЛАБОРАТОРНЫХ УСЛОВИЯХ
Аннотация
В обзоре приводится информация о разных моделях формирования цирроза печени в лабораторных условиях. Дана краткая характеристика патофизиологических, биохимических аспектов моделей, морфологическая картина цирроза печени в зависимости от способа моделирования.Литература
1. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J. Hepatol. 2013;58(3):593-608. doi: 10.1016 / j.jhep.2012.12.005.
2. He GL, Feng L, Cai L, Zhou CJ, Cheng Y, Jiang ZS, Pan MX, Gao Y. Artificial liver support in pigs with acetaminophen-induced acute liver failure. World J. Gastroenterol. 2017;23(18):3262-3268. doi: 10.3748 / wjg.v23.i18.3262.
3. Tonnesen K. Experimental liver failure. A comparison between hepatectomy and hepatic devascularization in the pig. Acta Chir. Scand. 1977;143(5):271-277.
4. Delire B, Stärkel P, Leclercq I. Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development. J. Clin. Transl. Hepatol. 2015;3(1):53-66. doi: 10.14218/JCTH.2014.00035.
5. Panis Y, McMullan DM, Emond JC. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery. 1997;121(2):142-149.
6. Lee SW, Kim SH, Min SO, Kim KS. Ideal Experimental Rat Models for Liver Diseases. Korean J. Hepatobiliary Pancreat. Surg. 2011;15(2):67-77. doi: 10.14701/kjhbps.2011.15.2.67.
7. Tuñón MJ, Alvarez M, Culebras JM, González-Gallego J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J. Gastroenterol. 2009;15(25):3086-3098.
8. Shirasugi N, Wakabayashi G, Shimazu M, Oshima A, Shito M, Kawachi S, Karahashi T, Kumamoto Y, Yoshida M, Kitajima M. Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury. Transplantation. 1997;64(10):1398-1403.
9. Tag CG, Sauer-Lehnen S, Weiskirchen S, Borkham-Kamphorst E, Tolba RH, Tacke F, Weiskirchen R. Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis. J. Vis. Exp. 2015;10(96). doi: 10.3791/52438.
10. Beier JI, McClain CJ. Mechanisms and cell signaling in alcoholic liver disease. Biol. Chem. 2010;391(11):1249-1264. doi: 10.1515/BC.2010.137.
11. Lopez MF, Grahame NJ, Becker HC. Development of ethanol withdrawal-related sensitization and relapse drinking in mice selected for high- or low-ethanol preference. Alcohol. Clin. Exp. Res. 2011;35(5):953-962. doi: 10.1111/j.1530-0277.2010.01426.x.
12. Morales-González JA, Sernas-Morales ML, Morales-González Á, González-López LL, Madrigal-Santillán EO, Vargas-Mendoza N, Fregoso-Aguilar TA, Anguiano-Robledo L, Madrigal-Bujaidar E, Álvarez-González I, Chamorro-Cevallos G. Morphological and biochemical effects of weekend alcohol consumption in rats: Role of concentration and gender. World J. Hepatol. 2018;10(2):297-307. doi: 10.4254/wjh.v10.i2.297.
13. Liu F, Chen L, Rao HY, Teng X, Ren YY, Lu YQ, Zhang W, Wu N, Liu FF, Wei L. Automated evaluation of liver fibrosis in thioacetamide, carbon tetrachloride, and bile duct ligation rodent models using second-harmonic generation/two-photon excited fluorescence microscopy. Lab. Invest. 2017;97(1):84-92. doi: 10.1038/labinvest.2016.128.
14. Liu X, Dai R, Ke M, Suheryani I, Meng W, Deng Y. Differential Proteomic Analysis of Dimethylnitrosamine (DMN)-Induced Liver Fibrosis. Proteomics. 2017;17(22):1700267. doi: 10.1002/pmic.201700267.
15. Skuratov AG, Lyzikov AN, Voropaev EV, Achinovich SL, Osipov BB. Jeksperimentalnoe modelirovanie toksicheskogo povrezhdenija pecheni [Experimental modeling of toxic hepatic injury]. Problemy zdorovja i jekologii [Problems of health and ecology]. 2011;(4):27-33. (Russian).
16. Lebedeva EI, Prudnikov VS, Mjadelec OD. Jeksperimentalnaja model toksicheskogo cirroza pecheni u belyh krys. Uchenye zapiski uchrezhdenija obrazovanija Vitebskaja ordena «Znak pocheta» gosudarstvennaja akademija veterinarnoj mediciny. 2015;5(1 Pt1):84-88. (Russian).
17. Strnad P, Tao GZ, Zhou Q, Harada M, Toivola DM, Brunt EM, Omary MB. Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models. Gastroenterology. 2008;134(4):1169-1179. doi: 10.1053/j.gastro.2008.01.035.
18. Caballero F, Fernandez A, Matias N, Martinez L, Fucho R, Elena M, Caballeria J, Morales A, Fernandez-Checa JC, Garcia-Ruiz C. Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. J. Biol. Chem. 201011;285(24):18528-18536. doi: 10.1074/jbc.M109.099333.
19. Hintermann E, Ehser J, Christen U. The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice. J. Vis. Exp. 2012;(60):e3644. doi: 10.3791/3644.
20. Andrade ZA, Santana TS. Angiogenesis and schistosomiasis. Mem. Inst. Oswaldo Cruz. 2010;105(4):436-439. doi: 10.1590/S0074-02762010000400013.
21. Thomas E, Liang TJ. Experimental models of hepatitis B and C – new insights and progress. Nat. Rev. Gastroenterol. Hematol. 2016;13(6):362-374. doi: 10.1038/nrgastro.2016.37.
22. Arutjunjan IV, Makarov AV, Fathudinov TH, Bolshakova GB. Modelirovanie cirroza pecheni na laboratornyh zhivotnyh [Liver cirrhosis models in laboratory animals]. Klinicheskaja i jeksperimentalnaja morfologija [The Journal of Clinical and Experimental Morphology]. 2012;(2):45-50. (Russian).
2.png)
